v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Activities    
Net Income $ 134 $ 111
Adjustments to reconcile Net Income to Net cash and cash equivalents from operating activities:    
Depreciation and amortization 69 63
Stock-based compensation 6 6
Amortization of operating lease right-of-use assets 4 4
Deferred income taxes 33 33
Earnings from equity method investees (43) (37)
Dividends from equity method investees 41 30
Changes in assets and liabilities:    
Accounts receivable, net 0 4
Accounts payable (3) (10)
Interest payable 38 38
Accrued compensation (14) (11)
Contract liabilities 1 3
Other current and noncurrent assets and liabilities 14 13
Net cash and cash equivalents from operating activities 280 247
Investing Activities    
Plant and equipment expenditures (78) (71)
Distributions from equity method investees 15 18
Contributions to equity method investees (5) (1)
Net cash and cash equivalents used for investing activities (68) (54)
Financing Activities    
Borrowings under the Revolving Credit Facility 90 35
Repayment of borrowings under the Revolving Credit Facility (90) (120)
Distributions to noncontrolling interests (5) (4)
Contributions from noncontrolling interests 1 2
Dividends paid on common stock (83) (75)
Stock-based compensation tax withholding payments (29) (16)
Net cash and cash equivalents used for financing activities (116) (178)
Net Increase in Cash and Cash Equivalents 96 15
Cash and Cash Equivalents at Beginning of Period 54 68
Cash and Cash Equivalents at End of Period 150 83
Cash paid for:    
Interest, net of interest capitalized 0 0
Income taxes, net of refunds received 2 (2)
Supplemental disclosure of non-cash investing and financing activities    
Plant and equipment expenditures in accounts payable and other accrued liabilities $ 45 $ 48